Divergent effects of a combined hormonal oral contraceptive on insulin sensitivity in lean versus obese women

Fertility and Sterility

Volumn 96, Issue 2, 2011, Pages

  Cheang, Kai I ^a,b   Essah, Paulina A ^a   Sharma, Susmeeta ^a   Wickham III, Edmond P ^a   Nestler, John E ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carbohydrate metabolism; cholesterol; insulin resistance; obesity; oral contraceptives

Indexed keywords

CHOLESTEROL; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS NORGESTIMATE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; NORGESTIMATE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARBOHYDRATE METABOLISM; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL RESEARCH; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HORMONAL CONTRACEPTION; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LIPOPROTEIN BLOOD LEVEL; OBESITY; ORAL CONTRACEPTION; PREMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79960646727     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.05.039     Document Type: Article

References (34)

1. A. Chandra, G.M. Martinez, W.D. Mosher, J.C. Abma, and J. Jones Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. National Center for Health Statistics Vital Health Stat 23 2005 1 160
2. Lamb E. Top 200 Drugs of 2008. Pharmacy Times May 2009. Available at: http://www.pharmacytimes.com/issue/pharmacy/2009/2009-05/RxFocusTop200Drugs- 0509. Accessed December 18, 2009.
3. V. Wynn, and J. Doar Some effects of oral contraceptives on carbohydrate metabolism Lancet ii 1966 715 719
4. V. Wynn, P.W. Adams, I. Godsland, J. Melrose, R. Niththyananthan, and N.W. Oakley Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism Lancet 1 1979 1045 1049 (Pubitemid 9177133)
5. L.M. Lopez, D.A. Grimes, and K.F. Schulz Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus Cochrane Database Syst Rev 4 2009 CD006133
6. G.M. Reaven The insulin resistance syndrome: definition and dietary approaches to treatment Annu Rev Nutr 25 2005 391 406 (Pubitemid 41209007)
7. R.T. Burkman Jr., M.E. Kafrissen, W. Olson, and J. Osterman Lipid and carbohydrate effects of a new triphasic oral contraceptive containing norgestimate Acta Obstet Gynecol Scand Suppl 156 1992 5 8
8. R.N. Bergman, Y.Z. Ider, C.R. Bowden, and C. Cobelli Quantitative estimation of insulin sensitivity Am J Physiol 236 1979 E667 E677
9. R.N. Bergman, R. Prager, A. Volund, and J.M. Olefsky Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp J Clin Invest 79 1987 790 800 (Pubitemid 17050904)
10. Y.J. Yang, J.H. Youn, and R.N. Bergman Modified protocols improve insulin sensitivity estimation using the minimal model Am J Physiol 253 1987 E595 E602
11. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, and B.A. Franklin Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement Circulation 112 2005 2735 2752 (Pubitemid 41532612)
12. G. Pacini, and R.N. Bergman MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test Comput Methods Programs Biomed 23 1986 113 122 (Pubitemid 16027716)
13. J.P. Le Floch, P. Escuyer, E. Baudin, D. Baudon, and L. Perlemuter Blood glucose area under the curve: methodological aspects Diabetes Care 13 1990 172 175 (Pubitemid 20056207)
14. M. Matsuda, and R.A. DeFronzo Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp Diabetes Care 22 1999 1462 1470 (Pubitemid 29418240)
15. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
16. J.W. Doar, and V. Wynn Effects of obesity, glucocorticoid, and oral contraceptive therapy on plasma glucose and blood pyruvate levels Br Med J 1 1970 149 152
17. I.F. Godsland The influence of female sex steroids on glucose metabolism and insulin action J Intern Med 240 Suppl 738 1996 1 60
18. I.F. Godsland, D. Crook, R. Simpson, T. Proudler, C. Felton, and B. Lees The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism N Engl J Med 323 1990 1375 1381
19. B. Runnebaum, K. Grunwald, and T. Rabe The efficacy and tolerability of norgestimate/ethinyl estradiol (250 micrograms of norgestimate/35 micrograms of ethinyl estradiol): results of an open, multicenter study of 59,701 women Am J Obstet Gynecol 166 1992 1963 1968
20. S.O. Skouby, O. Andersen, N. Saurbrey, and C. Kuhl Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes J Clin Endocrinol Metab 64 1987 519 523 (Pubitemid 17020918)
21. L.C. Morin-Papunen, I. Vauhkonen, R.M. Koivunen, A. Ruokonen, H.K. Martikainen, and J.S. Tapanainen Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study J Clin Endocrinol Metab 85 2000 3161 3168
22. L. Morin-Papunen, I. Vauhkonen, R. Koivunen, A. Ruokonen, H. Martikainen, and J.S. Tapanainen Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study J Clin Endocrinol Metab 88 2003 148 156 (Pubitemid 36115157)
23. A. Schaffler, U. Muller-Ladner, J. Scholmerich, and C. Buchler Role of adipose tissue as an inflammatory organ in human diseases Endocr Rev 27 2006 449 467 (Pubitemid 44213227)
24. B.E. Wisse The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity J Am Soc Nephrol 15 2004 2792 2800 (Pubitemid 41103388)
25. P.M. Ridker, C.H. Hennekens, N. Rifai, J.E. Buring, and J.E. Manson Hormone replacement therapy and increased plasma concentration of c-reactive protein Circulation 100 1999 713 716 (Pubitemid 29383640)
26. D. Cibula, M. Fanta, J. Vrbikova, S. Stanicka, K. Dvorakova, and M. Hill The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients Hum Reprod 20 2005 180 184
27. M. Guido, D. Romualdi, M. Giuliani, R. Suriano, L. Selvaggi, and R. Apa Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study J Clin Endocrinol Metab 89 2004 2817 2823 (Pubitemid 38766371)
28. L. Falsetti, and E. Pasinetti Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome Acta Obstet Gynecol Scand 74 1995 56 60
29. M. Luque-Ramirez, F. Alvarez-Blasco, J.I. Botella-Carretero, E. Martinez-Bermejo, M.A. Lasuncion, and H.F. Escobar-Morreale Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome J Clin Endocrinol Metab 92 2007 2453 2461 (Pubitemid 47037342)
30. O.R. Grigoryan, E.E. Grodnitskaya, E.N. Andreeva, M.V. Shestakova, G.A. Melnichenko, and I.I. Dedov Contraception in perimenopausal women with diabetes mellitus Gynecol Endocrinol 22 2006 198 206
31. L. Ibanez, and F. de Zegher Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity J Clin Endocrinol Metab 89 2004 1592 1597 (Pubitemid 38507907)
32. M.T. Korytkowski, M. Mokan, M.J. Horwitz, and S.L. Berga Metabolic effects of oral contraceptives in women with polycystic ovary syndrome J Clin Endocrinol Metab 80 1995 3327 3334
33. S.O. Skouby, C. Kuhl, L. Molsted-Pedersen, K. Petersen, and M.S. Christensen Triphasic oral contraception: metabolic effects in normal women and those with previous gestational diabetes Am J Obstet Gynecol 153 1985 495 500 (Pubitemid 16218443)
34. I. Wiegratz, C. Jung-Hoffmann, W. Gross, and H. Kuhl Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters Contraception 58 1998 83 91 (Pubitemid 28449361)